Dynamic platelet adhesion in patients with an acute coronary syndrome: The effect of antiplatelet therapy

References

• Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res 2007;100:1673–1685.
   PubMed Web of Science ®Google Scholar
• Casa LD, Ku DN. Geometric design of microfluidic chambers: Platelet adhesion versus accumulation. Biomed Microdevices 2014;16:115–126.
   PubMed Web of Science ®Google Scholar
• Lucitt MB, O’Brien S, Cowman J, Meade G, Basabe-Desmonts L, Somers M, Kent N, Ricco AJ, Kenny D. Assaying the efficacy of dual-antiplatelet therapy: Use of a controlled-shear-rate microfluidic device with a well-defined collagen surface to track dynamic platelet adhesion. Anal Bioanal Chem 2013;405:4823–4834.
   PubMed Web of Science ®Google Scholar
• Westerbacka J, Yki-Jarvinen H, Turpeinen A, Rissanen A, Vehkavaara S, Syrjälä M, Lassila R. Inhibition of platelet-collagen interaction: An in vivo action of insulin abolished by insulin resistance in obesity. Arterioscler Thromb Vasc Biol 2002;22:167–172.
   PubMed Web of Science ®Google Scholar
• Kalantzi KI, Tsoumani ME, Goudevenos IA, Tselepis AD. Pharmacodynamic properties of antiplatelet agents: Current knowledge and future perspectives. Expert Rev Clin Pharmacol 2012;5:319–336.
   PubMed Web of Science ®Google Scholar
• Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045–1057.
   PubMed Web of Science ®Google Scholar
• Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999–3054.
   PubMed Web of Science ®Google Scholar
• Li R, Diamond SL. Detection of platelet sensitivity to inhibitors of COX-1, P2Y1, and P2Y12 using a whole blood microfluidic flow assay. Thromb Res 2014;133:203–210.
   PubMed Web of Science ®Google Scholar
• Mitsios JV, Papathanasiou AI, Rodis FI, Elisaf M, Goudevenos JA, Tselepis AD. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes. Circulation 2004;109:1335–1338.
   PubMed Web of Science ®Google Scholar
• Kalantzi KI, Dimitriou AA, Milionis HJ, Goudevenos IA, Tselepis AD. Clopidogrel differentially affects platelet-mediated thrombosis and inflammatory response in patients with acute coronary syndromes. J Thromb Haemost 2011;9:875–878.
   PubMed Web of Science ®Google Scholar
• Tsoumani ME, Kalantzi KI, Dimitriou AA, Ntalas IV, Goudevenos IA, Tselepis AD. Effect of clopidogrel besylate on platelet reactivity in patients with acute coronary syndromes. Comparison with clopidogrel hydrogen sulfate. Expert Opin Pharmacother 2012;13:149–158.
   PubMed Web of Science ®Google Scholar
• Kalantzi KI, Dimitriou AA, Goudevenos JA, Tselepis AD. The platelet hyporesponsiveness to clopidogrel in acute coronary syndrome patients treated with 75 mg/day clopidogrel may be overcome within 1 month of treatment. Platelets 2012;23:121–131.
   PubMed Web of Science ®Google Scholar
• Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, Stone GW, Curzen N, Geisler T, Ten Berg J. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol 2013;62:2261–2273.
   PubMed Web of Science ®Google Scholar
• Skaer RJ, Flemans RJ, McQuilkan S. Mepacrine stains the dense bodies of human platelets and not platelet lysosomes. Br J Haematol 1981;49:435–438.
   PubMed Web of Science ®Google Scholar
• Turner NA, Moake JL, Kamat SG, Schafer AI, Kleiman NS, Jordan R, McIntire LV. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa. Circulation 1995;91:1354–1362.
   PubMed Web of Science ®Google Scholar
• Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996;84:289–297.
   PubMed Web of Science ®Google Scholar
• Dise CA, Burch JW, Goodman DB. Direct interaction of mepacrine with erythrocyte and platelet membrane phospholipid. J Biol Chem 1982;257:4701–4704.
   PubMed Web of Science ®Google Scholar
• Savage B, Ginsberg MH, Ruggeri ZM. Influence of fibrillar collagen structure on the mechanisms of platelet thrombus formation under flow. Blood 1999;94:2704–2715.
   PubMed Web of Science ®Google Scholar
• Tsimihodimos V, Kakafika A, Tambaki AP, Bairaktari E, Chapman MJ, Elisaf M, Tselepis AD. Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins. J Lipid Res 2003;44:927–934.
   PubMed Web of Science ®Google Scholar
• Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Miltiadous G, Goudevenos JA, Cariolou MA, Chapman MJ, Tselepis AD, Elisaf M. Altered distribution of platelet-activating factor: Acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia. J Lipid Res 2002;43:256–263.
   PubMed Web of Science ®Google Scholar
• Roest M, Reininger A, Zwaginga JJ, King MR, Heemskerk JW. Flow chamber-based assays to measure thrombus formation in vitro: requirements for standardization. J Thromb Haemost 2011;9:2322–2324.
   PubMed Web of Science ®Google Scholar
• Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood 1996;88:1525–1541.
   PubMed Web of Science ®Google Scholar
• Papathanasiou A, Goudevenos J, Tselepis AD. Aspirin resistance in cardiovascular disease: Pathogenesis, diagnosis and clinical impact. Curr Pharm Des 2009;15:1085–1094.
   PubMed Web of Science ®Google Scholar
• Patrono C, Coller B, Dalen JE, Fuster V, Gent M, Harker LA, Hirsh J, Roth G. Platelet-active drugs: The relationships among dose, effectiveness, and side effects. Chest 1998;114:470S–88S.
   PubMed Web of Science ®Google Scholar
• L.TP Valerio, Sheriff J., Brengle W., Ghosh R., Chiu WC., Redaelli, A., Fiore GB.,Pappalardo, F., Bluestein, D., Slepian, M. Aspirin has limited ability to modulate shear-mediated platelet activation associated with elevated shear stress of ventricular assist devices. Thrmbosis Research 2016;2016.
   Google Scholar
• Bozzo J, Hernandez MR, Galan AM, Heras M, Ordinas A, Escolar G. Impaired antiplatelet effects of aspirin associated with hypoxia and ATP release from erythrocytes. Studies in a system with flowing human blood. Eur J Clin Invest 1999;29:438–444.
   PubMed Web of Science ®Google Scholar
• Bossavy JP, Thalamas C, Sagnard L, Barret A, Sakariassen K, Boneu B, Cadroy Y. A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans. Blood 1998;92:1518–1525.
   PubMed Web of Science ®Google Scholar
• Cadroy Y, Bossavy JP, Thalamas C, Sagnard L, Sakariassen K, Boneu B. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation 2000;101:2823–2828.
   PubMed Web of Science ®Google Scholar
• Mendolicchio GL, Zavalloni D, Bacci M, Corrada E, Marconi M, Lodigiani C, Presbitero P, Rota L, Ruggeri ZM. Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood. J Thromb Haemost 2011;9:373–82.
   PubMed Web of Science ®Google Scholar
• Sakakibara M, Goto S, Eto K, Tamura N, Isshiki T, Handa S. Application of ex vivo flow chamber system for assessment of stent thrombosis. Arterioscler Thromb Vasc Biol 2002;22:1360–1364.
   PubMed Web of Science ®Google Scholar
• Escolar G, Bastida E, Castillo R, Ordinas A. Ticlopidine inhibits platelet thrombus formation studied in a flowing system. Thromb Res 1987;45:561–571.
   PubMed Web of Science ®Google Scholar
• Nuyttens BP, Thijs T, Deckmyn H, Broos K. Platelet adhesion to collagen. Thromb Res 2011;127 Suppl 2:S26–9.
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Watson SP. Platelet-collagen interaction: Is GPVI the central receptor? Blood 2003;102:449–461.
   PubMed Web of Science ®Google Scholar
• Jung SM, Moroi M. Activation of the platelet collagen receptor integrin alpha(2)beta(1): Its mechanism and participation in the physiological functions of platelets. Trends Cardiovasc Med 2000;10:285–292.
   PubMed Web of Science ®Google Scholar
• Tsoumani ME, Kalantzi KI, Goudevenos IA, Tselepis AD. Platelet-mediated inflammation in cardiovascular disease. Potential role of platelet-endothelium interactions. Curr Vasc Pharmacol 2012;10:539–549.
   PubMed Web of Science ®Google Scholar
• Adamski P, Kozinski M, Ostrowska M, Fabiszak T, Navarese EP, Paciorek P, Grześk G, Kubica J. Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors. Thromb Haemost 2014;112:224–242.
   PubMed Web of Science ®Google Scholar
• Li R, Diamond SL. Detection of platelet sensitivity to inhibitors of COX-1, P2Y(1), and P2Y(1)(2) using a whole blood microfluidic flow assay. Thromb Res 2014;133:203–210.
   PubMed Web of Science ®Google Scholar
• Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267–315.
   Google Scholar
• Colace TV, Tormoen GW, McCarty OJ, Diamond SL. Microfluidics and coagulation biology. Annu Rev Biomed Eng 2013;15:283–303.
   PubMed Web of Science ®Google Scholar
• Feghhi S, Sniadecki NJ. Mechanobiology of platelets: Techniques to study the role of fluid flow and platelet retraction forces at the micro- and nano-scale. Int J Mol Sci 2011;12:9009–9030.
   PubMed Web of Science ®Google Scholar
• Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998;94:657–666.
   PubMed Web of Science ®Google Scholar
• Inoue O, Suzuki-Inoue K, Ozaki Y. Redundant mechanism of platelet adhesion to laminin and collagen under flow: Involvement of von Willebrand factor and glycoprotein Ib-IX-V. J Biol Chem 2008;283:16279–16282.
   PubMed Web of Science ®Google Scholar
• Watson SP. Platelet activation by extracellular matrix proteins in haemostasis and thrombosis. Curr Pharm Des 2009;15:1358–13572.
   PubMed Web of Science ®Google Scholar
• Farndale RW, Sixma JJ, Barnes MJ, de Groot PG. The role of collagen in thrombosis and hemostasis. J Thromb Haemost 2004;2:561–573.
   PubMed Web of Science ®Google Scholar
• Heemskerk JW, Sakariassen KS, Zwaginga JJ, Brass LF, Jackson SP, Farndale RW. Collagen surfaces to measure thrombus formation under flow: possibilities for standardization. J Thromb Haemost 2011;9:856–858.
   PubMed Web of Science ®Google Scholar
• Cattaneo M, Cerletti C, Harrison P, Hayward CP, Kenny D, Nugent D, Nurden P, Rao AK, Schmaier AH, Watson SP, et al. Recommendations for the standardization of light transmission aggregometry: A consensus of the working party from the platelet physiology subcommittee of SSC/ISTH. J Thromb Haemost 2013; 11:1183–1189.
   Web of Science ®Google Scholar
• Lisman T, Adelmeijer J, Cauwenberghs S, Van Pampus EC, Heemskerk JW, De Groot PG. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count. J Thromb Haemost 2005;3:742–751.
   PubMed Web of Science ®Google Scholar